Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments

Title
Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments
Authors
Keywords
-
Journal
BIOCHEMICAL PHARMACOLOGY
Volume 151, Issue -, Pages 291-306
Publisher
Elsevier BV
Online
2018-02-02
DOI
10.1016/j.bcp.2018.01.043

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now